PC
HRMY icon

Prairiewood Capital’s Harmony Biosciences HRMY Stock Holding History

Prairiewood Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
+5,784
New +$182K 0.05% 73
2026
Q1 		– Sell
-6,203
Closed -$232K – 79
2025
Q4 		$232K Buy
+6,203
New +$204K 0.07% 66
2025
Q3 		– Sell
-10,483
Closed -$331K – 81
2025
Q2 		$331K Hold
10,483
– – 0.12% 59
2025
Q1 		$348K Sell
10,483
-490
-4% -$17.6K 0.14% 59
2024
Q4 		$378K Sell
10,973
-469
-4% -$16.1K 0.16% 58
2024
Q3 		$458K Hold
11,442
– – 0.19% 54
2024
Q2 		$345K Hold
11,442
– – 0.16% 60
2024
Q1 		$384K Buy
+11,442
New +$367K 0.18% 60

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prairiewood Capital's HRMY Position: Q2 2026 in Review

Prairiewood Capital opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 5,784 shares worth $211K. The stake represents 0.05% of the portfolio and ranks #73 among its holdings. This is a return to the name: Prairiewood Capital previously reported a position in HRMY as recently as Q4 2025.

Prairiewood Capital first reported a position in HRMY in Q1 2024 and has held it in 8 quarters since. The position peaked at $458K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Prairiewood Capital held 5,784 shares of Harmony Biosciences worth $211K as of Q2 2026.
  • Harmony Biosciences was a new Prairiewood Capital position in Q2 2026.
  • Harmony Biosciences made up 0.05% of Prairiewood Capital's portfolio in Q2 2026, its #73 holding.
  • Prairiewood Capital first reported a position in Harmony Biosciences in Q1 2024 and has held it in 8 quarters since.
  • Prairiewood Capital's Harmony Biosciences position peaked at $458K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Prairiewood Capital's 13F filing for Q2 2026, filed 28 Jul 2026.